Difference between revisions of "De los Rios C"
From Bioblast
Beno Marija (talk | contribs) |
Nirschl Lisa (talk | contribs) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 17: | Line 17: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== MitoEAGLE == | |||
****: '''Benefits for COST and for the COST Action MitoEAGLE''' | |||
:::: One of my research lines is the development of new ligands for the mitochondrial sodium/calcium exchanger (NCLX). Please find attached my recent papers. We also have a patent claiming the synthesis and therapeutic use of improved NCLX blockers (P201500509). | |||
:::: For these reasons, I would like to join the cost action CA15203 "Mitochondrial mapping: Evolution - Age - Gender - Lifestyle - Environment". I think that our participation would be of interest for the COST participants, as we could provide new chemical entities capable to be used as pharmacological tools to study mitochondria. | |||
Latest revision as of 09:25, 19 January 2018
 |
News and Events |  |
 |
Working Groups | Short-Term Scientific Missions | Management Committee | Members |  |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
De los Rios C
MitoPedia topics: EAGLE
COST: Member
COST WG4: WG4
| Name | De los Rios Cristobal, PhD |
|---|---|
| Institution | Associate Researcher
Institute of Health Research Hospital Universitario de la Princesa |
| Address | , |
| City | Madrid |
| State/Province | |
| Country | Spain |
| [email protected] | |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Martinez-Sanz 2016 Eur J Med Chem | 2016 | Martínez-Sanz FJ, Lajarín-Cuesta R, González-Lafuente L, Moreno-Ortega AJ, Punzón E, Cano-Abad MF, de los Ríos C (2016) Neuroprotective profile of pyridothiazepines with blocking activity of the mitochondrial Na+/Ca2+ exchanger. Eur J Med Chem 109:114-23. |
| Martinez-Sanz 2015 ACS Chem Neurosci | 2015 | Martínez-Sanz FJ, Lajarín-Cuesta R, Moreno-Ortega AJ, González-Lafuente L, Fernández-Morales JC, López-Arribas R, Cano-Abad MF, de los Ríos C (2015) Benzothiazepine CGP37157 analogues exert cytoprotection in various in vitro models of neurodegeneration. ACS Chem Neurosci 6:1626-36. |
Abstracts
MitoEAGLE
- Benefits for COST and for the COST Action MitoEAGLE
- One of my research lines is the development of new ligands for the mitochondrial sodium/calcium exchanger (NCLX). Please find attached my recent papers. We also have a patent claiming the synthesis and therapeutic use of improved NCLX blockers (P201500509).
- For these reasons, I would like to join the cost action CA15203 "Mitochondrial mapping: Evolution - Age - Gender - Lifestyle - Environment". I think that our participation would be of interest for the COST participants, as we could provide new chemical entities capable to be used as pharmacological tools to study mitochondria.
